AHIP Pushes Back on HHS Efforts To Ensure Non-Discrimination in Plan Design
In its 2023 Notice of Benefit and Payment Parameters Proposed Rule (2023 NBPP), the U.S.…
Browsing: Multimedia
Food and Drug Administration Issues Guidance on Race and Ethnicity Diversity Plans for Clinical Trials
On April 13, the Food and Drug Administration published a draft guidance on “Diversity Plans…
Michigan Expands Postpartum Coverage for Up To 12 Months
On April 14, 2022, Michigan joined a growing number of states that can now offer…
White House Proposes to Fix “Family Glitch” in the ACA
On April 5, 2022, the Biden Administration announced that the Treasury Department and the Internal…
Aimed Alliance Sends Letter of Support to Minnesota Legislature on Copay Accumulator Reform
On March 25, 2022, Aimed Alliance sent a letter to the Minnesota House of Representatives…
Aimed Alliance Hosts Webinar on Covering Prescription Digital Therapeutics: A Win-Win for Employers and Employees
On March 29, 2022, Aimed Alliance hosted a webinar through HR.com titled “Covering Prescription Digital…
New Resources Educate Decisionmakers on Insurance Coverage of Rx Digital Therapies
Aimed Alliance Teams with HR.com, Center for U.S. Policy, Others To Inform Corporate Executives, Members…
Aimed Alliance joins 31 Organizations and Patient Advocacy Groups in Applauding Congress for Introducing Legislation That Would Expand Access to Prescription Digital Therapies.
On March 25, 2022, Aimed Alliance and 31 other not-for-profit organizations and patient-advocacy groups sent…
Federal Government Facilitates Access To Prescription Digital Behavioral Therapies
WASHINGTON, March 23, 2022 /PRNewswire/ — Today, Aimed Alliance, the Center for U.S. Policy and the International Health…
Aimed Alliance Submits Letter of Support for Kentucky Step-Therapy Reform
On March 1, 2022, Aimed Alliance sent a letter to members of the Kentucky House…